| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 294.57× | 294.57× | 537.50× | 0.00× | 0.00× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 152.04× | 152.04× | 303.29× | 1,449.57× | 71,338.71× | ||
| 517.22× | 517.22× | 1,545.40× | 4,839.47× | 2,47,507.00× | ||
| −70.61× | −70.61× | −704.61× | −3,389.90× | −1,76,168.29× | ||
| −8.24× | −6.32× | −0.78× | −0.08× | −0.00× | ||
| 0.35× | 0.35× | 0.16× | 0.03× | 0.00× | ||
| 1.44× | 1.44× | −8.55× | 0.79× | −0.86× | ||
| 1.47× | 1.47× | 1.47× | 1.17× | −6.46× |
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 0.00 | 0.00 | 537.50 | 294.57 | 294.57 | |
| Receivable Days (DSO) | 71,338.71 | 1,449.57 | 303.29 | 152.04 | 152.04 | |
| Payable Days (DPO) | 2,47,507.00 | 4,839.47 | 1,545.40 | 517.22 | 517.22 | |
| Cash Conversion Cycle (days) | -1,76,168.29 | -3,389.90 | -704.61 | -70.61 | -70.61 | |
| Working Capital Turnover | -0.00 | -0.08 | -0.78 | -6.32 | -8.24 | |
| Asset Turnover | 0.00 | 0.03 | 0.16 | 0.35 | 0.35 | |
| Cash Conversion (CFO/Net Income) | -0.86 | 0.79 | -8.55 | 1.44 | 1.44 | |
| CFO/EBITDA | -6.46 | 1.17 | 1.47 | 1.47 | 1.47 |